Beranda › Penyakit Paru › Distrik Columbia › Washington
Uji klinis Penyakit Paru di Washington, DC
10 studi untuk Penyakit Paru mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
- Research Site, Washington D.C.
Study of the Disease Process of Lymphangioleiomyomatosis
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
- Georgetown University Medical Center, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi jauhnya
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi jauhnya
Study of Lung Proteins in Patients With Pneumonia
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Site 1001, Washington D.C.
Role of Genetic Factors in the Development of Lung Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Sibley Memorial Hospital, Washington D.C.
Cooperative Assessment of Late Effects for SCD Curative Therapies
Menerima pesertaStudi observasional
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Uji klinis Penyakit Paru di kota lain
- Houston, TX15 studi
- Boston, MA14 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Pittsburgh, PA11 studi
- Dallas, TX10 studi
- Miami, FL10 studi
- Columbus, OH10 studi
- Nashville, TN10 studi
- Los Angeles, CA10 studi
- Ann Arbor, MI10 studi
- Birmingham, AL9 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Metastatik43 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Kanker Kandung Kemih26 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.